Search Knowledge Base

12 results for "iron-chelating-agents"

Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson's disease: A systematic review and meta-analysis pubmed_article
Evidence Source 2024 PMID: 38334258
Amlodipine as adjuvant therapy to current chelating agents for reducing iron overload in thalassaemia major: a systematic review, meta-analysis and simulation of future studies pubmed_article
Evidence Source 2021 PMID: 33634883
Effects of dietary chromium picolinate supplementation on broiler growth performance: A meta-analysis pubmed_article
Evidence Source 2021 PMID: 33822801
Coadministration of silymarin with iron chelators in transfusion-dependent β-thalassemia patients: a systematic review and meta-analysis for effect on iron overload pubmed_article
Evidence Source 2021 PMID: 34486906
Systematic review and meta-analysis of the effect of iron chelation therapy on overall survival and disease progression in patients with lower-risk myelodysplastic syndromes pubmed_article
Evidence Source 2019 PMID: 30413901
Deferasirox for managing iron overload in people with myelodysplastic syndrome pubmed_article
Evidence Source 2014 PMID: 25348770
Iron chelators for acute stroke pubmed_article
Evidence Source 2012 PMID: 22972139
Deferasirox for managing iron overload in people with myelodysplastic syndrome pubmed_article
Evidence Source 2010 PMID: 21069694
Oral deferiprone for iron chelation in people with thalassaemia pubmed_article
Evidence Source 2007 PMID: 17636775
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia pubmed_article
Evidence Source 2005 PMID: 16235363
Chromium picolinate for reducing body weight: meta-analysis of randomized trials pubmed_article
Evidence Source 2003 PMID: 12664086
Iron chelating agents for treating malaria pubmed_article
Evidence Source PMID: 10796645

Evidence Search Results semantic · quality-ranked

Efficacy of the iron-chelating agent, deferiprone, in patients with Parkinson's disease: A systematic review and meta-analysis meta_analysis pubmed_article
Quality: 73 2024 PMID: 38334258 DOI: 10.1111/cns.14607
Amlodipine as adjuvant therapy to current chelating agents for reducing iron overload in thalassaemia major: a systematic review, meta-analysis and simulation of future studies meta_analysis pubmed_article
Quality: 58 2021 PMID: 33634883 DOI: 10.1111/vox.13083
Iron chelators for acute stroke systematic_review pubmed_article
Quality: 65 2020 PMID: 33236783 DOI: 10.1002/14651858.CD009280.pub3
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia meta_analysis pubmed_article
Quality: 72 2018 PMID: 29737522 DOI: 10.1002/14651858.CD012349.pub2
Iron Preparations in the Management of Iron Deficiency Anemia in Infants and Children: A Systematic Review and Meta-Analysis meta_analysis pubmed_article
Quality: 52 2023 PMID: 37209050
Deferasirox for managing iron overload in people with thalassaemia meta_analysis pubmed_article
Quality: 67 2017 PMID: 28809446 DOI: 10.1002/14651858.CD007476.pub3
The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. cochrane_review cochrane_review
Quality: 64 PMID: 26845108 DOI: 10.1002/14651858.CD009624.pub2
Serum Biomarkers of Iron Status and Risk of Primary Liver Cancer: A Systematic Review and Meta-Analysis meta_analysis pubmed_article
Quality: 52 2019 PMID: 31044614 DOI: 10.1080/01635581.2019.1609053
Oral deferiprone for iron chelation in people with thalassaemia meta_analysis pubmed_article
Quality: 71 2013 PMID: 23966105 DOI: 10.1002/14651858.CD004839.pub3
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia meta_analysis pubmed_article
Quality: 71 2013 PMID: 23963793 DOI: 10.1002/14651858.CD004450.pub3

View full evidence search →